ArticleFrontiers in immunology2022

Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.

Mark B Carascal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.